BAYER DIAGNOSTICS ACS:180 AND ADVIA CENTAUR TROPONIN I ASSAY— 510(k) K993309

Substantially Equivalent

Bayer Corp.

FDA 510(k) clearance K993309 for BAYER DIAGNOSTICS ACS:180 AND ADVIA CENTAUR TROPONIN I ASSAY, Substantially Equivalent on 1999-12-06. Applicant: Bayer Corp..

Clearance details

Applicant: Bayer Corp.
Product code: Code MMI
Advisory panel: Clinical Chemistry
Date received: 1999-10-04
Decision date: 1999-12-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code MMI

product code MMI

Injury: 172
Malfunction: 3,762
Total: 3,934

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.